Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain?

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochemical Pharmacology

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(91)90646-M
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of MPTP on the cerebrovasculature

  1991cited by this paper
• MPTP toxicity in the mouse brain and vitamin E.

  1990cited by this paper
• Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice.

  1990cited by this paper
• Chemically induced Parkinson's disease. II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form.

  1989cited by this paper
• Abnormalities of the electron transport chain in idiopathic parkinson's disease

  1989cited by this paper
• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  1989cited by this paper
• Perturbations in cerebral oxygen radical formation and membrane order following vitamin E deficiency.

  1989cited by this paper
• Subcellular localization of superoxide dismutases, glutathione peroxidase and catalase in developing rat cerebral cortex.

  1989cited by this paper
• The acute histopathology of MPTP in the mouse CNS.

  1989cited by this paper
• Regional Distribution of Cytochrome P‐450 in the Rat Brain: Spectral Quantitation and Contribution of P‐450b,e and P‐450c,d

  1988cited by this paper
• Studies on the Toxicity of MPTP to Dopamine Neurons in Tissue and Cell Cultures

  1988cited by this paper
• Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.

  1988cited by this paper
• MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis.

  1988cited by this paper
• Oxygen activation during the interaction between MPTP metabolites and synthetic neuromelanin--an ESR-spin trapping, optical, and oxidase electrode study.

  1988cited by this paper
• (-)-2-Oxo-4-thiazolidine carboxylic acid attenuates 1-methyl-4-phenyl-1,1,2,3,6-tetrahydropyridine induced neurotoxicity

  1988cited by this paper
• Mechanisms of MPP+ Neurotoxicity: Oxyradical and Mitochondrial Inhibition Hypotheses

  1988cited by this paper
• Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo.

  1988cited by this paper
• The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.

  1988cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro.

  1988cited by this paper
• Increased nigral iron content in postmortem parkinsonian brain.

  1987cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.

  1987cited by this paper
• Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

  1987cited by this paper
• Evidence for the one-electron oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+).

  1987cited by this paper
• Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity.

  1987cited by this paper
• The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.

  1987cited by this paper
• Immunohistochemical localization of cytochrome P-450 in rat brain.

  1987cited by this paper
• MPTP fails to induce lipid peroxidation in vivo.

  1987cited by this paper
• Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum.

  1987cited by this paper
• The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice.

  1987cited by this paper
• MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygen.

  1987cited by this paper
• Transient nigral ubiquinone depletion after single MPTP administration in mice.

  1987cited by this paper
• Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.

  1987cited by this paper
• Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion.

  1987cited by this paper
• Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes.

  1987cited by this paper
• Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.

  1987cited by this paper
• Histochemical evaluation of glutathione in brain.

  1987cited by this paper
• N‐Methyl‐4‐phenylpyridine (MMP+ together with 6‐hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria

  1986cited by this paper
• Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.

  1986cited by this paper
• 1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent.

  1986cited by this paper
• Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.

  1986cited by this paper
• Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

  1986cited by this paper
• Regional Distributions of Thiobarbituric Acid‐Reactive Products, Activities of Enzymes Regulating the Metabolism of Oxygen Free Radicals, and Some of the Related Enzymes in Adult and Aged Rat Brains

  1986cited by this paper
• Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase.

  1986cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina.

  1986cited by this paper
• Brain anoxia releases striatal dopamine in rats.

  1986cited by this paper
• The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals.

  1985cited by this paper
• Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation.

  1985cited by this paper
• Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1985cited by this paper
• 16 – Oxidative Stress in the Nervous System

  1985cited by this paper
• Distinct monoamine oxidase A and B populations in primate brain.

  1985cited by this paper
• Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.

  1985cited by this paper
• Mechanism of chemical-induced toxicity. I. Use of a rapid centrifugation technique for the separation of viable and nonviable hepatocytes.

  1985cited by this paper
• Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.

  1985cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.

  1985cited by this paper
• Ascorbic acid reduces the dopamine depletion induced by MPTP.

  1985cited by this paper
• Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparations.

  1984cited by this paper
• The regional distribution and cellular localization of iron in the rat brain.

  1984cited by this paper
• Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones

  1984cited by this paper
• Plasma glutathione disulfide as an index of oxidant stress in vivo: effects of carbon tetrachloride, dimethylnitrosamine, nitrofurantoin, metronidazole, doxorubicin and diquat.

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Age‐Related Changes in Aldehyde Dehydrogenase Activity of Rat Brain, Liver, and Heart

  1983cited by this paper
• Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress.

  1983cited by this paper
• Penicillin-sensitive streptococcal endocarditis.

  1982cited by this paper
• Parkinson's disease: A disorder due to nigral glutathione deficiency?

  1982cited by this paper
• Status of the mitochondrial pool of glutathione in the isolated hepatocyte.

  1982cited by this paper
• Regional Distribution of Catalase in the Adult Rat Brain

  1981cited by this paper
• Activation of adenylate cyclase of rat brain by lipid peroxidation.

  1981cited by this paper
• Superoxide-and Ethane-Formation in Subchloroplast Particles: Catalysis by Pyridinium Derivatives

  1980cited by this paper
• Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines.

  1979cited by this paper
• Hydroperoxide metabolism in mammalian organs.

  1979cited by this paper
• Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

  1979cited by this paper
• Brain peroxidase and catalase in Parkinson disease.

  1975cited by this paper
• Histochemical Demonstration of Ascorbic Acid in the Locus Coeruleus of the Mammalian Brain

  1960cited by this paper
• Previously Published Works Uc Irvine Title: Effects of Mptp, Mpp+ and Paraquat on Mitochondrial Potential and Oxidative Stress

  year unknowncited by this paper

• Possible causes of Parkinson's disease.

  2021cites this paper
• Glutathione in Brain Aging and Neurodegenerative Disorders

  2018cites this paper
• Mitochondrial control of cell bioenergetics in Parkinson's disease.

  2016cites this paper
• Therapeutic potential of immune privileged Sertoli cells

  2015cites this paper
• Chapter 6 – Use of Caenorhabditis elegans to Model Human Movement Disorders

  2015cites this paper
• Botanical Phenolics and Neurodegeneration

  2011cites this paper
• Herbal medicine

  2011cites this paper
• Dietary alpha-tocopherol and neuromuscular health: search for optimal dose and molecular mechanisms continues!

  2010cites this paper
• 23 Neural Lipids in Parkinson's Disease

  2009cites this paper
• Botanical Phenolics and Brain Health

  2008cites this paper
• 15 Glutathione in the Nervous System: Roles in Neural Function and Health and Implications for Neurological Disease

  2007cites this paper
• Topological and chronological features of the impairment of glucose metabolism induced by 1-methyl-4-phenylpyridinium ion (MPP+) in rat brain slices

  2007cites this paper
• EFFECT OF EGB761 SUPPLEMENTATION ON METALLOTHIONEIN I + II EXPRESSION AFTER 1-METHYL-4-PHENYLPYRIDINIUM NEUROTOXICITY

  2007influential citation
• Short communication Topological and chronological features of the impairment of glucose metabolism induced by 1-methyl-4-phenylpyridinium ion (MPP 1 ) in rat brain slices

  2007cites this paper
• Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices.

  2007cites this paper
• Acetylsalicylic acid and acetaminophen protect against MPP+-induced mitochondrial damage and superoxide anion generation.

  2006cites this paper
• Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+-induced toxicity in PC12 cells

  2006cites this paper
• Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment.

  2006cites this paper
• Neuroprotective effects of cystamine in aged parkinsonian mice.

  2006cites this paper
• Effect of 1-methyl-4-phenylpyridinium (MPP+) on mitochondrial membrane potential in cerebellar neurons: Interaction with the NMDA receptor

  2005cites this paper
• CHAPTER A8 – Use of C. elegans to Model Human Movement Disorders

  2005cites this paper
• Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity

  2005cites this paper
• Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.

  2005cites this paper
• EGb761 Pretreatment Reduces Monoamine Oxidase Activity in Mouse Corpus Striatum During 1-Methyl-4-Phenylpyridinium Neurotoxicity

  2004cites this paper
• The neuromelanin of human substantia nigra: physiological and pathogenic aspects.

  2004cites this paper
• Metallothionein Inducers Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity in Mice

  2004cites this paper
• MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells.

  2003cites this paper
• The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.

  2003cites this paper
• D‐deprenyl protects nigrostriatal neurons against 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurotoxicity

  2003cites this paper
• 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine–induced lipid peroxidation and DNA damage in mouse bone marrow and blood

  2003cites this paper
• Regional selectivity in ethanol-induced pro-oxidant events within the brain.

  2003cites this paper
• 00442-0 REGIONAL SELECTIVITY IN ETHANOL-INDUCED PRO-OXIDANT EVENTS WITHIN THE BRAIN

  2003cites this paper
• MPTP: insights into parkinsonian neurodegeneration.

  2002cites this paper
• Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain.

  2002cites this paper
• Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo.

  2001cites this paper
• EGb761 Blocks MPP+-Induced Lipid Peroxidation in Mouse Corpus Striatum

  2001cites this paper
• Mechanisms of MPP(+) incorporation into cerebellar granule cells.

  2001cites this paper
• Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour

  2001cites this paper
• Neurochemical Mechanisms Underlying Neuroprotective Actions of Bromocriptine, Salicylate, d- and L-Deprenyl in Neurodegeneration caused by MPTP

  2000cites this paper
• Changes of metallothionein I + II proteins in the brain after 1-methyl-4-phenylpyridinium administration in mice.

  2000cites this paper
• Paraquat is a Model Environmental Neurotoxin for Studying Parkinson’s Disease

  2000cites this paper
• MPTP Decreases MT-I mRNA In Mouse Striatum

  2000cites this paper
• Pathogenesis and preclinical course of Parkinson's disease.

  1999cites this paper
• Striatal Metabolism of Hexanal, a Lipid Peroxidation Product, in the Rat

  1999cites this paper
• The pharmacological properties of the novel peptide BPC 157 (PL-10)

  1999cites this paper
• A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine.

  1999cites this paper
• 1‐Methyl‐4‐phenyl‐2,3‐dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1‐methyl‐4‐phenylpyridinium

  1999cites this paper
• Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

  1999cites this paper
• Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.

  1999cites this paper
• MPTP-Parkinsonism is accompanied by persistent expression of a delta-FosB-like protein in dopaminergic pathways.

  1998cites this paper
• A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine.

  1998cites this paper
• Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.

  1998cites this paper
• Oxidative damage and fibrogenesis.

  1997cites this paper
• L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.

  1997cites this paper
• Intramolecular ADP-ribose transfer reactions and calcium signalling. Potential role of 2'-phospho-cyclic ADP-ribose in oxidative stress.

  1997cites this paper
• Variability in susceptibility of the nervous system to toxic insult.

  1996cites this paper
• Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.

  1996cites this paper
• Depletion of copper and manganese in brain after MPTP treatment of mice.

  1995cites this paper
• Neurotoxicity, drugs of abuse, and the CuZn-superoxide dismutase transgenic mice

  1995cites this paper
• Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture.

  1995cites this paper
• Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system.

  1995cites this paper
• The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis

  1994cites this paper
• Quinolinic acid but not MK-801 protects the dopaminergic system from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in goldfish retina.

  1994cites this paper
• The neuropathology of intracerebroventricular t-butylhydroperoxide.

  1994cites this paper
• MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels

  1994cites this paper
• Free radicals and the pathogenesis of neuronal death: cooperative role of excitatory amino acids.

  1994cites this paper
• 1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.

  1994cites this paper
• Intranigral Iron Infusion as a Model for Parkinson’s Disease

  1994cites this paper
• What is it that l‐deprenyl (selegiline) might do? *

  1994cites this paper
• The biochemical mechanisms of the toxic effects of some pyridine derivatives. 1. Study on the deamination of biogenic amines and other nitrogenous compounds in paraquat intoxication

  1994cites this paper
• Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice.

  1993cites this paper
• Lipid Peroxidation. An Overview

  1993cites this paper
• MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes.

  1993cites this paper
• A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC.

  1993cites this paper
• Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.

  1993cites this paper
• CHAPTER 10 – MPTP and neurotoxins induced neuronal cell death

  1993cites this paper
• New aspects of brain oxidative stress induced by tert-butylhydroperoxide.

  1993cites this paper
• Lipid peroxidation. Biopathological significance.

  1993cites this paper
• The possible role of iron in the etiopathology of parkinson's disease

  1993cites this paper
• Contributory mechanisms in the causation of neurodegenerative disorders.

  1993cites this paper
• Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

  1993cites this paper
• Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease

  1993cites this paper
• Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?

  1992cites this paper
• MPP+ Redox Cycling: A New Mechanism Involving Hydride Transfer

  1992cites this paper
• Enhancement of the uptake of 1-methyl-4-phenylpyridinium ion (MPP+) in mitochondria by tetraphenylboron.

  1992cites this paper
• Reactive Oxygen Species and the Central Nervous System

  1992cites this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

  1992cites this paper
• Novel S‐Adenosylmethionine‐Dependent Indole‐N‐Methylation of β‐Carbolines in Brain Particulate Fractions

  1992cites this paper
• Oxygen free radicals and Parkinson's disease.

  1991cites this paper
• Oxidative stress as a cause of Parkinson's disease

  1991cites this paper